2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$3.49-$0.02 (-0.57%)
Price as of Sep 11, 2026 7:30 PM EDT- $332.3MMarket Cap
- 135.57%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$3.49-$0.02 (-0.57%)
ZNTL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.51 | ||
Change | -$0.08 (-2.23%) | ||
Open | $3.63 | ||
High | $3.67 | ||
Low | $3.46 | ||
Previous Close | $3.59 | ||
Volume | 787,858 | ||
30-Day Average Volume | 1,084,744 | ||
1-Week Change | -12.03% | ||
1-Month Change | -14.60% | ||
1-Year Change | 135.57% | ||
3-Year Change | -85.93% | ||
5-Year Change | -94.96% | ||
Fundamentals | |||
Shares Outstanding | 94.7M | ||
Total Assets | $215.3M | ||
Market Cap | $332.3M | ||
Enterprise Value | $307.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$42.3M | ||
Free Cash Flow | -$37.2M | ||
EBIT | -$42.1M | ||
EBITDA | -$42.0M | ||
Net Working Capital | $143.7M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue